BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28946004)

  • 1. Reference interval mean clotting times should not be used to calculate lupus anticoagulant mixing test ratios unless they match the normal pooled plasma clotting time.
    Moore GW
    Thromb Res; 2017 Nov; 159():16-18. PubMed ID: 28946004
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
    Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
    Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved method for lupus anticoagulant detection.
    Alonso I; Vandermijnsbrugge F; Vanremoortele E; Bradstreet C; Efira A; Cantinieaux B
    Haematologica; 2005 Apr; 90(4):564-5. PubMed ID: 15820959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
    Moore GW
    Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus anticoagulant detection: out of control?
    Moore GW; Brown KL; Bromidge ES; Drew AJ; Ledford-Kraemer MR
    Int J Lab Hematol; 2013 Apr; 35(2):128-36. PubMed ID: 22978522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clotting time and kaolin clotting time].
    Amagai H; Murakami M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():581-3. PubMed ID: 15658394
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 11. To mix with pooled normal plasma or not to mix: a comparative study of 2 approaches for assessing lupus anticoagulant inhibitory activity in the dilute Russell viper venom method.
    Aboud M; Roddie C; Ward C; Coyle L
    Clin Chem; 2007 Jan; 53(1):143-5. PubMed ID: 17202500
    [No Abstract]   [Full Text] [Related]  

  • 12. To mix or not to mix in lupus anticoagulant testing? That is the question.
    Tripodi A
    Semin Thromb Hemost; 2012 Jun; 38(4):385-9. PubMed ID: 22618530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
    Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
    Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
    Devreese KM
    Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lupus anticoagulant (LA)].
    Gohchi K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():694-6. PubMed ID: 15658426
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixing studies for abnormal coagulation screen - the current trend.
    Mohammad E; Thachil J
    Clin Chem Lab Med; 2017 Mar; 55(3):e54-e55. PubMed ID: 27522100
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria.
    Awodu OA; Ejele OA; Shokunbi WA; Enosolease ME
    Niger Postgrad Med J; 2003 Mar; 10(1):19-22. PubMed ID: 12812147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conceptions and misconceptions in testing for lupus anticoagulants.
    Exner T
    J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of unexpected lupus anticoagulant during preparation of normal pooled plasma (NPP) from healthy volunteers.
    Ghosh K; Shetty S; Mohanty D
    Thromb Haemost; 2000 Sep; 84(3):519-21. PubMed ID: 11019985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.